ABSTRACT
Acknowledgments .........................................................................................................................329
References .....................................................................................................................................329
Formulation changes in the form of altered surface treatments are known to frequently occur for a
variety of commercialized particle-types. The R-100 formulation of rutile-type titanium dioxide is a
well-known low-toxicity particulate. This study was designed as a pulmonary screening tool to
determine whether Pigment A TiO